|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 332.12Cr 291.97Cr 271.79Cr 249.6Cr 468.69Cr 32TCr 474.87Cr 3.23TCr 1.26TCr 16TCr 1.25TCr 1.22TCr 54TCr | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 347.73Cr 305.69Cr 284.56Cr 261.33Cr 490.71Cr 33TCr 497.18Cr 3.38TCr 1.32TCr 16TCr 1.31TCr 1.28TCr 57TCr | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/25/30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/25/30 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/25/30 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/25/30 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/25/24 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 1 year | 96.88 | 101.02 | |
| 3 years | 82.15 | 101.02 | |
| 5 years | 69.36 | 264.1 | |
| 10 years | 34.58 | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Chief Financial Officer | 1,58,296 | 0.4833% | ||
| 14/08/25 | Issuer sale | Investor Relations Manager | 53,082 | 0.1621% | ||
| 14/08/25 | Issuer sale | Compliance Officer | 40,579 | 0.1239% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 223.64Cr 196.6Cr 183.01Cr 168.07Cr 315.6Cr 21TCr 319.76Cr 2.18TCr 849.6Cr 11TCr 839.52Cr 821.42Cr 37TCr | 234.83Cr 206.44Cr 192.17Cr 176.48Cr 331.4Cr 23TCr 335.76Cr 2.28TCr 892.13Cr 11TCr 881.54Cr 862.54Cr 38TCr |
| Net income | -97.47L -85.69L -79.76L -73.25L -1.38Cr -93Cr -1.39Cr -9.48Cr -3.7Cr -46Cr -3.66Cr -3.58Cr -159.53Cr | 4.32Cr 3.8Cr 3.54Cr 3.25Cr 6.1Cr 414.58Cr 6.18Cr 42Cr 16Cr 204.71Cr 16Cr 16Cr 707.56Cr |
| Net Debt | 36Cr 32Cr 30Cr 27Cr 51Cr 3.46TCr 52Cr 350.91Cr 137.05Cr 1.71TCr 135.43Cr 132.51Cr 5.9TCr | 16Cr 14Cr 13Cr 12Cr 22Cr 1.5TCr 22Cr 151.8Cr 59Cr 738.99Cr 59Cr 57Cr 2.55TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
















